Biotech
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 08/29/11 -- Bio-Solutions Corp. (OTCBB: BISU) (PINK SHEETS: BISU) is proud to announce the appointment of Mr. Bill Gallagher of Jag Capital Inc, as Executive Vice ...
MONTREAL, QUEBEC: - 57% premium to recent share price - Provides fair value, liquidity and certainty ...
MADISON, WI: MADISON, WI -- (Marketwire) -- 08/29/11 -- Gentel Biosciences, a provider of animal health research products, announces today an agreement with Oregon Health & Science University (OHSU) to licens ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwire) -- 08/26/11 -- Afexa Life Sciences Inc. (TSX: FXA) today announced the encouraging results of an interim analysis performed by an independent data monitoring commit ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 08/26/11 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Company") a biopharmaceutical company specializing in the research and develop ...
NORTHBROOK, IL: NORTHBROOK, IL -- (Marketwire) -- 08/25/11 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the 2011 S ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 08/25/11 -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") (TSX VENTURE: BMR.H) today announced its second quarter 2011 operational ...
CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwire) -- 08/25/11 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS) ("SCT" or the "Company") today announced its results for the period ended June 30, ...
OSLO, NORWAY: OSLO, NORWAY -- (Marketwire) -- 08/25/11 --The study will determine:1. The ability of Vacc-4x to improve immune function in patients that fail to regain a healthy immune defense despite that their vir ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 08/24/11 -- Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Chief Executive Officer, is scheduled to present at the following inves ...
TUSTIN, CA: Encouraging Overall Survival Data Show Consistent Trend With Earlier Tumor Response Rate and PFS Data; Data Further Support Ongoing Randomized Phase II Trial Evaluating Bavituximab With Docetaxel for ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwire) -- 08/23/11 -- Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX: FXA) - the maker of COLD-FX® - today announced that its Board of Direc ...
ROCKVILLE, MD: ROCKVILLE, MD -- (Marketwire) -- 08/23/11 -- MarketResearch.com has announced the addition of the new report "Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) - Current Tren ...
STOCKHOLM, SWEDEN: Fred Hassan, Chairman of Bausch + Lomb and Former CEO of Pharmacia, Returns to Sweden to Deliver a Keynote Address on the Importance of Innovation in Ophthalmology ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 08/22/11 -- Corcept Therapeutics (NASDAQ: CORT) today announced the appointment of Gary C. ("Charlie") Robb to the position of Chief Financial Officer, ef ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 08/22/11 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 08/22/11 -- The Board of RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB: REPCF) today announced that it has appoi ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 08/22/11 -- (NASDAQ: PRAN) (ASX: PBT), announced today that the company has received a grant* from The Michael J. Fox Foundation (MJFF) to support the initiat ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 08/19/11 -- RXT 110 INC. (CNSX: RXT) (the "Company") announced today that Mr. Donald Meade has resigned as a director of the Company.About RXT 110 Inc.R ...
SOUTH SAN FRANCISCO, CA: Results From These Trials Form the Basis for Ongoing Phase IIb Activities in Collaboration With Amgen ...
